Literature DB >> 30811356

Editorial Comment: 2017 Musculoskeletal Tumor Society Proceedings.

John H Healey1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30811356      PMCID： PMC6437377          DOI： 10.1097/CORR.0000000000000653

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  5 in total

Review 1.  Advances in the treatment of advanced oestrogen-receptor-positive breast cancer.

Authors:  Nicholas C Turner; Patrick Neven; Sibylle Loibl; Fabrice Andre
Journal:  Lancet       Date:  2016-12-07       Impact factor: 79.321

2.  The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study.

Authors:  Jenny J Ko; Wanling Xie; Nils Kroeger; Jae-Lyun Lee; Brian I Rini; Jennifer J Knox; Georg A Bjarnason; Sandy Srinivas; Sumanta K Pal; Takeshi Yuasa; Martin Smoragiewicz; Frede Donskov; Ravindran Kanesvaran; Lori Wood; D Scott Ernst; Neeraj Agarwal; Ulka N Vaishampayan; Sun-Young Rha; Toni K Choueiri; Daniel Y C Heng
Journal:  Lancet Oncol       Date:  2015-02-12       Impact factor: 41.316

Review 3.  Current Landscape of Targeted Therapy in Lung Cancer.

Authors:  Manasi K Mayekar; Trever G Bivona
Journal:  Clin Pharmacol Ther       Date:  2017-09-25       Impact factor: 6.875

Review 4.  Molecular alterations in triple-negative breast cancer-the road to new treatment strategies.

Authors:  Carsten Denkert; Cornelia Liedtke; Andrew Tutt; Gunter von Minckwitz
Journal:  Lancet       Date:  2016-12-07       Impact factor: 79.321

Review 5.  HER2-positive breast cancer.

Authors:  Sibylle Loibl; Luca Gianni
Journal:  Lancet       Date:  2016-12-07       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.